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Review question(s)
To what extent do clinical, behavioural and pharmacogenomic factors affect the response to levothyroxine therapy in
patients with primary hypothyroidism?
Searches
The following databases will be searched: Web of Science, MEDLINE (Ovid) and PubMed.
Any publication period will be used, and language will be restricted to English only. Articles will also be identified
from reference lists.
Types of study to be included
All potential studies will be initially accepted; RCTs, case studies, observational studies, retrospective audits etc.
Condition or domain being studied
Overt or subclinical hypothyroidism and TSH levels
Participants/ population
Inclusion criteria: Adults aged 18 or older, with history of hypothyroidism and receiving levothyroxine treatment.
Exclusion criteria: Children (aged less than 18 years), patients on other forms of hormone replacement therapy or
combination therapy, pregnant women, patients with secondary hypothyroidism, patients previously treated for
hyperthyroidism.
Intervention(s), exposure(s)
Clinical, behavioural and pharmacogenomic interventions. Any intensity and frequency with length of intervention
greater than 6 weeks.
Comparator(s)/ control
A control or comparative group is necessary. This can be placebo/no treatment/standard therapy/ usual care/
alternative treatment.
Outcome(s)
Primary outcomes
The quantitative effect of clinical/ behavioural/pharmacogenomic factors on TSH levels.
Secondary outcomes
Effects on T4 and T3 levels, any short term effects, mortality, morbidity, quality of life, treatment complications,
adverse effects, physical functioning, social functioning.
Data extraction, (selection and coding)
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Studies will be screened through reading the title, abstract and then full text. Two reviewers will independently
participate in the extraction of data and the selection of articles. If there is disagreement between the reviewers, a
third reviewer will be consulted.
The following data will be extracted from articles that meet the inclusion criteria:
1) Authors, year of publication, country, study design, number of patients
2) Population demographics
3) Reason for hypothyroidism
4) Co-morbidities
5) Levothyroxine dose ＠ጀ＠range/average
6) TSH levels 
7) Intervention; type, duration etc.
Risk of bias (quality) assessment
Articles will be assessed referring to the GRADE guidelines. Two reviewers will assess articles for quality to reduce
bias. Any disagreement will be resolved by consulting with a third reviewer.
Strategy for data synthesis
A four-phase flow diagram will be created depicting the search strategy used during the review, and the numbers of
articles excluded and included, and on what basis (PRISMA). A combined narrative synthesis of the findings from the
included studies will be provide. A summary of the difference between the mean TSH levels of patients from various
interventions will be presented. A summary of the effect of various attributes affecting TSH control will be presented.
Descriptive summary tables will also be created.
Analysis of subgroups or subsets
None planned
Dissemination plans
Findings will be disseminated at conferences and in professional and peer-reviewed journals.
Contact details for further information
Dr Dew
Department of Pharmacy, Health and Wellbeing
Sciences Complex
City Campus
Chester Road
Sunderland
SR1 3SD
University of Sunderland
rosie.dew@sunderland.ac.uk
Organisational affiliation of the review
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University of Sunderland
http://www.sunderland.ac.uk/faculties/apsc/ourdepartments/phw/
Review team
Dr Rosie Dew, University of Sunderland
Professor Scott Wilkes, University of Sunderland
Dr Onyebuchi Okosieme, Cardiff University School of Medicine
Professor Colin Dayan, Cardiff University School of Medicine
Dr Vinay Eligar, Cardiff University School of Medicine
Professor Simon Pearce, Institute of Human Genetics
Dr Salman Razvi, Queen Elizabeth Hospital
Anticipated or actual start date
01 October 2015
Anticipated completion date
06 June 2016
Funding sources/sponsors
Not applicable
Conflicts of interest
None known
Language
English
Country
England, Wales
Subject index terms status
Subject indexing assigned by CRD
Subject index terms
Humans; Hypothyroidism; Pharmacogenetics; Thyrotropin; Thyroxine
Stage of review
Ongoing
Date of registration in PROSPERO
15 December 2015
Date of publication of this revision
15 December 2015
Stage of review at time of this submission Started Completed
Preliminary searches Yes   No 
Piloting of the study selection process   Yes   No 
Formal screening of search results against eligibility criteria   Yes   No 
Data extraction   No   No 
Risk of bias (quality) assessment   No   No 
Data analysis   No   No 
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